May 2008
Volume 49, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2008
Involvement of ER in Protective Effect of 17β-Estradiol Against TNF--Induced Optic Nerve Degeneration
Author Affiliations & Notes
  • Y. Hayashi
    Ophthalmology, Shinkawabashi Hospital, Kawasaki-shi, Japan
  • Y. Kitaoka
    Ophthalmology, St Marianna Univ Sch of Med, Kawasaki-shi, Japan
  • H. Takeda
    Ophthalmology, St Marianna Univ Sch of Med, Kawasaki-shi, Japan
  • H. Fujino
    Ophthalmology, St Marianna Univ Sch of Med, Kawasaki-shi, Japan
  • S. Ueno
    Ophthalmology, St Marianna Univ Sch of Med, Kawasaki-shi, Japan
  • Footnotes
    Commercial Relationships  Y. Hayashi, None; Y. Kitaoka, None; H. Takeda, None; H. Fujino, None; S. Ueno, None.
  • Footnotes
    Support  None.
Investigative Ophthalmology & Visual Science May 2008, Vol.49, 4938. doi:https://doi.org/
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Y. Hayashi, Y. Kitaoka, H. Takeda, H. Fujino, S. Ueno; Involvement of ER in Protective Effect of 17β-Estradiol Against TNF--Induced Optic Nerve Degeneration. Invest. Ophthalmol. Vis. Sci. 2008;49(13):4938. doi: https://doi.org/.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : We previously reported the neuroprotective effect of 17β-estradiol (E2) through phosphorylation of extracellular signal-regulated kinase (ERK) /mitogen-activated protein kinase (MAPK) pathway in TNF-α-induced axonal degeneration. The purpose of present study is to investigate the change in estrogen receptor α (ERα) expression and its relationship to the axon death in TNF-α-induced optic nerve degeneration.

Methods: : Eight-week-old female and male Wistar rats were used as subjects. Female rats were divided into sham operated and ovariectomized (OVX) groups. The OVX rats were treated with either solvent vehicle or E2 subcutaneous implant immediately after ovariectomy. At 14 days post-operation, all rats were received intravitreal injection of 10 ng TNF-α or PBS. The eyes were enucleated 1, 7, or 14 days after intravitreal injection. The expression of ERα was examined by Western blot analysis. The localization of ERα in optic nerve cross section as well as transverse section was evaluated by immunohistochemistry.

Results: : Western blot analysis and immunohistochemistry showed the existence of ER in the optic nerve. They were co-localized with neurofilament, but not with vimentin in the optic nerve from normal subjects. There was a significant decrease in ERα protein level in the optic nerve 14 days after TNF-α injection. Substantial decrease in neurofilament immunoreactivity was observed in TNF-α-treated eyes with vehicle implantation and this depletion was ameliorated by E2 implantation.

Conclusions: : Existence of ERα in axon and close relationship between ERα and neurofilament suggest that E2 can exert direct axonal protection without cell body involvement against TNF-α-induced axonal degeneration.

Keywords: neuroprotection • optic nerve • neuro-ophthalmology: optic nerve 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×